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The Hsp90 chaperone cycle catalyzes the final activation step of several important eukaryotic proteins
(Hsp90 “clients”). Although largely a functional form of Hsp90, an Hsp90-Gal4p DNA binding domain fusion
(Hsp90-BD) displays no strong interactions in the yeast two-hybrid system, consistent with a general tran-
sience of most Hsp90-client associations. Strong in vivo interactions are though detected when the E33A
mutation is introduced into this bait, a mutation that should arrest Hsp90-client complexes at a stage where
the client is stabilized, yet prevented from attaining its active form. This E33A mutation stabilized the
two-hybrid interactions of the Hsp90-BD fusion with 3% of the Saccharomyces cerevisiae proteome in a screen
of the 6,000 yeast proteins expressed as fusions to the Gal4p activation domain (AD). Among the detected
interactors were the two stress-activated mitogen-activated protein (MAP) kinases of yeast, Hog1p and Slt2p
(Mpk1p). Column retention experiments using wild-type and mutant forms of Hsp90 and Slt2p MAP kinase,
as well as quantitative measurements of the effects of stress on the two-hybrid interaction of mutant Hsp90-BD
and AD-Slt2p fusions, revealed that Hsp90 binds exclusively to the dually Thr/Tyr-phosphorylated, stress-
activated form of Slt2p [(Y-P,T-P)Slt2p] and also to the MAP kinase domain within this (Y-P,T-P)Slt2p.
Phenotypic analysis of a yeast mutant that expresses a mutant Hsp90 (T22Ihsp82) revealed that Hsp90 function
is essential for this (Y-P,T-P)Slt2p to activate one of its downstream targets, the Rlm1p transcription factor.
The interaction between Hsp90 and (Y-P,T-P)Slt2p, characterized in this study, is probably essential in this
Hsp90 facilitation of the Rlm1p activation by Slt2p.
Hsp90 is an essential and abundant molecular chaperone of
eukaryotic cells. It orchestrates the chaperone cycle that cata-
lyzes the final activation step of several of their key signaling
and regulatory proteins (targets hereafter designated Hsp90
“clients”). Rather than acting at an early stage of protein
folding, Hsp90 binds these clients when they are already sub-
stantially folded, so as to induce the structural changes and
protein associations whereby they attain their full activity. A
number of cochaperone proteins assist in these events, becom-
ing associated with the Hsp90-based complex at different steps
of the multistage chaperone cycle (reviewed in references 8,
45, 46, 48, 50, and 71).
One of the best-understood events of client activation cata-
lyzed by this chaperone cycle is the process whereby certain
steroid hormone receptors (SHRs) become competent for ste-
roid binding. Here the cochaperone p60/Hop is present in the
early-stage Hsp90-SHR complexes, prior to the attainment of
the steroid-activatable state. These early complexes then pro-
gress to later-stage, more mature Hsp90-SHR complexes, where
the SHR is competent for activation though the binding of the
steroid. In these later-stage complexes, certain other cochape-
rones (p23 and also immunophilins such as Cyp40 and FKBP52)
have replaced p60/Hop in the Hsp90-based complex (48). In
some instances the association of a cochaperone with the Hsp90-
client complex may be specific for a particular class of client.
Thus, Hsp90 complexes with protein kinases often contain p50/
Cdc37p, whereas those with SHRs generally do not (48, 59).
Proteins tend to be identified as Hsp90 clients on an ad hoc
basis, as workers identify their protein of interest as having
Hsp90 binding properties and an activity that is susceptible to
highly selective inhibitors of Hsp90 function (notably the an-
tibiotics geldanamycin and radicicol). Hsp90 is frequently also
identified by mass spectrometry as a component of multipro-
tein complexes (63). No in vivo screen for identifying Hsp90
interactors has yet been developed. In this report we describe
a modification of the yeast two-hybrid system that allows such
a screen. One of the novel interactions discovered in this way,
that between Hsp90 and a mitogen-activated protein (MAP)
kinase, is characterized in detail. Kinases of the MAP kinase
class constitute the terminal kinases of phosphorylation cas-
cades controlling cell proliferation, differentiation, stress re-
sponses, and cell survival (27, 60, 61). These important protein
kinases are not generally considered Hsp90 clients, though
certain kinases modestly related to conventional MAP kinases
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are known to bind Hsp90 (39). Nevertheless, through protein
binding studies and genetic analysis, we revealed that the func-
tion of the Hsp90 chaperone is essential for one stress-activat-
ed MAP kinase, Slt2p (Mpk1p), to activate a downstream tar-
get. Hsp90 binding by this Slt2p is selective for the dually Tyr/
Thr-phosphorylated, stress-activated form of the MAP kinase.
MATERIALS AND METHODS
Construction of “bait” constructs comprising mutant versions of the Hsp90-
BD fusion. Saccharomyces cerevisiae expressing point mutant forms of yeast
Hsp82 with a C-terminal Gal4p binding domain (BD) extension (mutant
Hsp82-BD fusions) were constructed by a slight modification of the procedure
used to make the strains expressing a native, wild-type Hsp82-BD fusion (see
reference 38 for details). Instead of using the wild-type HSP82 gene as a template
in the first of two sequential PCRs, well-characterized mutant hsp82 alleles from
an earlier study were employed (49). Strain PJ69-4 (MAT trp1-901 leu2-3,112
ura3-52 his3-200 gal4 gal80 LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-
lacZ) (20) was then transformed with the product of the second PCR and
NcoI-digested pBDC, so as to generate the gene encoding the mutant Hsp82-BD
fusion by homologous recombination within the yeast (38). Transformants were
initially selected by plating on dropout agar medium (DO) lacking tryptophan (3)
and then checked for the presence of the correct fusion gene by colony PCR
(using the same primers as in the second round of the above PCR amplification)
and by Western blotting (using an anti-Gal4p BD antiserum [Clontech]).
Two-hybrid screening of protein interactions. Baits in PJ69-4 were checked
for self-activation by plating onto DO minus tryptophan and histidine and con-
taining increasing concentrations (0 to 8 mM) of 3-amino-1,2,4-triazole (3-AT).
Having ensured, from the absence of appreciable growth, that the introduced
mutations did not lead to self-activation, these baits in PJ69-4 were mated to
PJ69-4a (20) transformants from an earlier study (37), the latter expressing
fusions of the Gal4p activation domain (AD) to known Hsp90 system cochap-
erones and Hsp90 clients. They were also mated to a previously described (64)
16-plate, 384-well format array of yeast AD-protein fusions carried in strain
PJ69-4a. All replications and inoculations were carried out using the 96- or
384-pin replicators of a Biomek 2000 Laboratory Automation Workstation, with
movements programmed using the BioWorks Version software (Beckman).
After mating, PJ69-4 diploids were selected by plating onto DO minus leucine
and tryptophan. Screening for protein-protein interactions was by the pinning of
these diploids onto DO lacking leucine, tryptophan, and histidine and supple-
mented with increasing concentrations (0 to 20 mM) of 3-AT. Growth on these
plates was scored after 4, 10, and 16 days at 30°C. As with the earlier screens of
the AD-protein fusion array (37, 64), two identically performed matings of each
bait to the array were conducted.
Measurements of interaction-responsive lacZ expression. Automated mea-
surement of -galactosidase activity due to the basal and stress-induced expres-
sion of the interaction-responsive, GAL7 promoter-regulated lacZ gene of
PJ69-4 was done essentially as described previously(37); data shown (see Fig. 3
and 4) are the means and standard deviations of eight assays. The control cells
were those containing pBDC (38) lacking any gene insert and the pOAD-derived
plasmid for the expression of the AD fusion, since the basal lacZ expression in
this system is generally due to the AD-protein fusion, and cells containing the
vector for Hsp82-BD expression and empty pOAD display an even lower basal
lacZ expression that is unaffected by stress (37).
Protein binding studies. TRP1 vectors for TDH1 promoter-regulated expres-
sion of a C terminally His6-tagged wild-type Hsp82 (Hsp82-His6) and also an
E33A or D79N mutant form of this Hsp82-His6 were constructed by PCR
amplifying the appropriate wild-type or mutant HSP82 genes from the plasmid
DNAs of an earlier study (43) (primer sequences available on request). Products
of these PCRs were then digested with BamHI plus SalI, prior to insertion into
BamHI-plus-XhoI-cleaved pG1 (55).
A URA3 vector for MET25 promoter-regulated expression of a C terminally
His6-tagged Slt2p (Slt2-His6) was constructed by first PCR amplifying the SLT2
gene from yeast chromosomal DNA, using primers GGACTAGTATGGCTGA
TAAGATAGAGAGG and CCATCGATCTAATGATGATGATGATGATGAC
CAGGTTCGTCAGCTGGATCATGCCA (restriction sites underlined; His-tag
sequence in bold). This was then inserted as a SpeI/ClaI fragment into pUT36
(pUT36 being pUG36 (http://www.mips.biochem.mpg.de/proj/yeast/info/tools
/hegemann/gfp/html) with the XbaI fragment containing the green fluorescent
protein gene excised). Plasmids for Slt2(T190A,Y192F)-His6 and Slt2(K54R)-
His6 expression were derived from this vector using the QuickChange Mutagen-
esis kit (Stratagene), the introduced mutations being confirmed by sequencing.
These Slt2-His6, Slt2(T190A,Y192F)-His6, and Slt2(K54R)-His6 expression vec-
tors were then inserted into p82aslt2 (a strain constructed by kanMX4 cassette
deletion of the chromosomal SLT2 gene of p82a (40). The MKK1S386P gene was
also inserted into pUT36, but as an XbaI/XhoI fragment PCR amplified from the
vector described by Watanabe et al. (65).
Preparation of total yeast protein extracts was as described previously (43), the
different forms of Slt2p-His6 or Hsp82-His6 in these extracts being isolated using
nickel-nitrilotriacetate (Ni-NTA) chromatography. Western blot analysis of yeast
Hsp90, Slt2p, and Sba1p used, as the primary antibody, rabbit polyclonal antisera
raised against these proteins. Analysis of His6- tagged proteins used a mouse
tetra-His antibody (QIAGEN). The secondary antibody was horseradish perox-
idase–anti-rabbit or –anti-mouse immunoglobulin G (Amersham) diluted 2,000-
fold. Analysis of the active form of Slt2p used an anti-(Thr202/Tyr204)-p44/42
MAP kinase antiserum (New England Biolabs) which specifically recognizes the
dually Thr190/Tyr192-phosphorylated Slt2p in yeast extracts (34). Enhanced
chemiluminescence reagents (Amersham) were used for detection. Measure-
ments of Rlm1p transcription factor activity used a YIL117c promoter-lacZ
reporter plasmid (22).
RESULTS
A genomic screen for two-hybrid interactions strongly rein-
forced by the E33A mutation in an Hsp90-BD bait fusion. The
yeast two-hybrid system detects in vivo protein-protein associ-
ation as the reconstitution of transcription factor activity, the
DNA binding domain (BD) and the activation domain (AD) of
this transcription factor being expressed on different protein
fusions. Reconstitution of an active transcription factor re-
quires these BD- and AD-bearing fusions (“bait” and “prey,”
respectively) to associate noncovalently in the yeast nucleus
(3). In proteome-wide screens it is generally an interaction-
responsive HIS3 gene that is monitored (64), an activity scored
as growth over 4 to 16 days in the absence of histidine and the
presence of 3-AT (an inhibitor of the HIS3 product). Growth
under these conditions requires a high, sustained activation of
the HIS3 gene and therefore a relatively long-lived, stable
association of the “bait” and “prey” fusions. It is unlikely that
the in vivo associations of Hsp90 with its clients could be
readily detected by such a system, as these tend to be rather
transient (involving a chaperone cycle thought to take place
over a time scale of minutes (52, 57). Indeed, two-hybrid bait
fusions comprising the Gal4p BD positioned at the C terminus
of either isoform of yeast Hsp90 (Hsp82-BD or Hsc82-BD)
display just a few, weak interactions when screened against the
complete yeast proteome expressed as fusions to the Gal4p
AD (37, 38). To detect Hsp90 interactors by an in vivo screen
of this nature, it would probably be necessary to increase very
considerably the length of time that these are in association
with Hsp90 (i.e., to slow the chaperone cycle at a stage where
the client is both stable and chaperone bound).
It is thought that the ATPase reaction of Hsp90 constitutes
the rate-limiting step of the Hsp90 chaperone cycle, this ATP
turnover rate therefore determining the length of time a client
is bound by Hsp90 (35, 49, 69). We therefore investigated if it
might be possible to stabilize the two-hybrid associations of an
Hsp82-BD fusion by the mutation in this fusion of glutamate
33, the residue acting as a general base in the ATPase reaction
of Hsp90 (51). Such a mutation should inhibit the final ATPase
step of the chaperone cycle but allow this cycle to progress to
a late-stage complex where the client is stabilized in association
with the ATP-bound Hsp90 (43).
Strain PJ694 was engineered to express an E33A mutant
form of Hsp82-BD, [Hsp82(E33A)-BD; see Materials and
Methods]. Also constructed was an Hsp82(D79N)-BD fusion
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where the sole amino acid of the N-terminal domain of yeast
Hsp82 that directly contacts the bound ATP/ADP is mutated,
leading to loss of ADP/ATP binding by the chaperone (43). As
neither mutation caused the Hsp82-BD fusion to self-activate,
PJ694 cells expressing either Hsp82(E33A)-BD, Hsp82(D79N)-
BD, or the control (Hsp82-BD) fusion, were mated to cells of
the opposite mating type (PJ694a) that express AD fusions to
different cochaperones or AD fusions to some of the known
Hsp90 clients of yeast (AD-Ste11p [31], AD-Gcn2p [10],
and AD-Hap1p [29]). The resultant diploids were next rep-
licated onto DO lacking tryptophan, leucine, or histidine but
containing either 4 or 8 mM 3-AT, and the plates then
incubated at 30°C.
The presence of the E33A mutation in the Hsp82-BD fusion
generated strong two-hybrid interactions with most of these
cochaperones and known Hsp90 clients, as shown by growth of
the yeast in the presence of 4 mM 3-AT (Fig. 1). In contrast,
the D79N mutation generated no such effect (only the AD-
Gcn2p interaction appearing to be reinforced by D79N in this
initial screen [Fig. 1], a result not investigated further). Since
this preliminary analysis had indicated that the E33A mutation
was reinforcing Hsp82-BD interactions to a sufficient extent to
allow a genomic screen for the in vivo binding partners of
Hsp90, Hsp82(E33A)-BD and the control Hsp82-BD fusion
were next introduced into the previously described 16-plate,
384-colony format array of colonies of the opposite mating
type, each of which expresses a different AD-yeast protein
fusion (64) (see Materials and Methods). Following mating,
the cells were pinned onto DO minus tryptophan or leucine,
thereby selecting the diploids expressing both Hsp82(E33A)-BD
(or the control Hsp82-BD) and an AD-protein fusion. These
diploid colonies were next transferred to DO minus tryptophan,
leucine, or histidine but containing 4, 8, or 20 mM 3-AT. Then,
after 4, 8, and 16 days of growth at 30°C, the colonies scoring
positive for HIS3 gene activation were identified from their
growth at distinct positions on the arrays. As self-activators can
arise in two-hybrid screens by spontaneous mutation of the
interactor fusions (3), the mating of each bait to the genomic
array of AD-yeast protein fusions was performed in duplicate,
the positive interacting partners being scored as the “double
hits” identified in both of the identically executed screens.
Figure 2a shows three sample plates from the 16-plate array
of AD-fusion expressor cells (64) following their mating to
PJ694 cells expressing either the control fusion (Hsp82-BD)
or the E33A mutant fusion [Hsp82(E33A)-BD] and their sub-
sequent growth (now as diploids expressing both AD and BD
fusions) in the presence of 3-AT. Note that only a few of the
384 colonies on each plate are exhibiting 3-AT-resistant growth
dependent upon the presence of the E33A mutation in the bait
fusion. In total, some 177 proteins (3% of the total yeast
proteome) were identified as potential Hsp82 interactors on
the basis of such strong stabilization of their two-hybrid inter-
action by the E33A mutation in the Hsp82-BD fusion. These
are listed in Table 1, together with their apparent interaction
FIG. 1. Effects of the E33A and D79N mutations in an Hsp82-BD
bait fusion on two-hybrid interaction of this fusion with selected Hsp90
system cochaperones and clients. Growth was for 12 days at 30°C on
DO lacking leucine, tryptophan, and histidine and supplemented with
4 mM 3-AT.
FIG. 2. The presence of the E33A mutation in the Hsp82-BD bait
fusion stabilizes certain interactions with the library array of yeast
AD-protein fusions. (a) Three sample 384-colony format plates of the
16-plate library array (64), containing either the Hsp82-BD or the
Hsp82(E33A)-BD baits, as indicated. The numbered interactors with
the latter are as follows: 1, ACT1; 2, YCL056c; 3, OLE1; 4, NUP57; 5,
SLT2; 6, PDR3; and 7, ESC5. Growth was for 16 days at 30°C on DO
minus leucine, tryptophan, and histidine and supplemented with 4 mM
or 8 mM 3-AT. (b) Analysis of Ni-NTA-retained material in extracts
from unstressed PJ694 cells expressing either Hsp82-His6, Hsp82
(E33A)-His6, or Hsp82(D79N)-His6. The Western blot was probed
with anti-actin, anti-Slt2p, and anti-His6 antisera.
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TABLE 1. Two-hybrid interactors with the Hsp82(E33A)-BD bait fusion
ORFc Gene Inta Function of gene productb
Known or putative Hsp90
system cochaperones
YDR214w AHA1 2 Nonessential cochaperone which binds the middle domain of Hsp90 (36) and activates the Hsp90
ATPase (44)
YDR168w CDC37 1 Essential Hsp90 system cochaperone; believed to target protein kinases to the Hsp90 chaperone
machine (32)
YBR155w CNS1 1 Essential Hsp90 system cochaperone
YKL117w SBA1 2 Nonessential Hsp90 system cochaperone; binds the N-terminal Hsp90 domain in mature Hsp90-
client complexes, probably assisting client protein release (69)
YOR027w STI1 1 Nonessential stress-induced protein that interacts with both Hsp70 and Hsp90 through its TPR
domains (72)
YOR035c SHE4 3 Nonessential protein required for mother cell-specific expression of homothallic switching endo-
nuclease; equivalent of the UNC45 myosin-specific chaperone, of metazoans (2); though fungal
forms of She4p lack the Hsp90-interacting TPR domain of UNC45 (16), the yeast She4p still
binds Hsp90 (S. H. Millson, unpublished data)
YPL106c SSE1 1 Nonessential form of Hsp110, a member of a subgroup of Hsp70 family chaperones (56)
YCR060w TAH1 2 Nonessential protein with TPR repeats and similarity to Sti1p
YNL064c YDJ1 2 DnaJ homolog; activator of the ATPase of Hsp70
Other stress proteins, chap-
erones, chaperonins
YDL143w CCT4 1 Component of chaperonin-containing T complex (TCP ring complex, TRiC), required for the as-
sembly of actin and tubulins in vivo
YOL053c-a DDR2 1 Stress protein induced by DNA damage, heat shock, osmotic shock, and oxidative stress
YOR020c HSP10 1 Mitochondrial chaperonin that cooperates with Hsp60p; homolog of E. coli GroES
YDR171w HSP42 2 Heat shock protein with similarity to Hsp26p; involved in restoration of the cytoskeleton during
mild stress
YLR259c HSP60 1 Mitochondrial chaperonin that cooperates with Hsp10p; homolog of E. coli GroEL
Cytoskeleton
YFL039c ACT1 2 Actin, critical for cell polarization, endocytosis, and other cytoskeletal functions
YNL079c TPM1 2 Tropomyosin, coiled-coil protein localized to actin cables
YHR107c CDC12 2 Component of 10-nm filaments of mother-bud neck (septin); involved in cytokinesis.
Protein kinases
YDR283c GCN2 2 Kinase that phosphorylates translation initiation factor eIF2; known Hsp90 client protein (10)
YLR113w HOG1 2 MAP kinase of the high-osmolarity signal transduction pathway
YGR040w KSS1 1 MAP kinase involved in signal transduction pathways that control filamentous growth and phero-
mone response
YHR030c SLT2 2 MAP kinase of the cell wall integrity (hypotonic stress-activated) pathway
YLR362w STE11 1 MAP kinase kinase kinase of the Hog1p and Kss1p MAP kinase pathways; known Hsp90 client
protein (31)
YHR135c YCK1 1 Casein kinase I isoform
Known or putative tran-
scriptional activators
YLR256w HAP1 2 Heme-responsive Zn(2)-Cys(6) binuclear cluster domain transcription factor; redox-sensing regu-
lator of gene expression; known Hsp90 client protein (29)
YBL005w PDR3 2 Zn(2)-Cys(6) binuclear cluster domain transcription factor; regulator of genes of pleiotropic drug
resistance
YCR029c-a RIM1 1 Zinc finger single-stranded DNA-binding protein; required for mitochondrial genome mainte-
nance
YKR064w YKR064w 1 Zn(2)-Cys(6) binuclear cluster domain protein with similarity to transcription factors
Known or putative regula-
tors of transcriptional
silencing or telomere
organizations
YJL076w ESC5 2 Involved in chromatin silencing, has similarity to Tof2p
YMR263w SAP30 2 Subunit of a histone deacetylase complex
YDL042c SIR2 1 NAD-dependent histone deacetylase; involved in maintenance of silencing at HMRd, HMLd, and
telomeres
YOR229w WTM2 1 Transcriptional modulator protein involved in meiotic regulation and silencing
Protein import or export
from the nucleus
YJR074w MOG1 2 Involved in nuclear protein import; potential Cdc28p substrate
YJR132w NMD5 3 Beta-karyopherin; involved in nuclear import
YGR119c NUP57 2 Nuclear pore protein (nucleoporin) that acts in a complex with Nic96p, Nup49p, and Nsp1p
Ras superfamily small
GTPases
YOR101w RAS1 1 GTP-binding protein involved in regulation of cyclic AMP pathway; homolog of mammalian
proto-oncogene ras
Continued on following page
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TABLE 1—Continued
ORFc Gene Inta Function of gene productb
YML001w YPT7 2 GTP-binding protein of the Rab family (Ras superfamily) with a role in protein transport between
endosome-like compartments
YER031c YPT31 2 GTP-binding protein of the Rab family (Ras superfamily) required in the secretory pathway at
the stage of formation of trans-Golgi vesicles
YNL093w YPT53 2 GTP-binding protein of the Rab family (Ras superfamily) involved in endocytosis and transport of
proteins to the vacuole
Other proteins of vesicle
trafficking
YLR078c BOS1 2 Synaptobrevin (v-SNARE) homolog involved in endoglasmic reticulum (ER)-to-Golgi transport
YAL042w ERV46 2 Protein localized to Sec31p-coated vesicles
YOR036w PEP12 2 Syntaxin homolog (t-SNARE) involved in Golgi-to-vacuole transport
YKL006c-a SFT1 2 v-SNARE required for vesicle traffic between Golgi compartments
YOL018c TLG2 1 Syntaxin homolog (t-SNARE) involved in endocytosis and maintenance of resident proteins in the
trans-Golgi network
YDR084c TVP23 2 Integral membrane protein localized to vesicles along with the v-SNARE Tlg2p
YJR044c VPS55 2 Vacuolar protein sorting; involved in Golgi-to-vacuole targeting
YGL161c YIP5 2 Protein that interacts with Rab GTPases; possible role in vesicle-mediated transport
Known or putative mem-
brane transporters
YBR132c AGP2 2 General amino acid permease
YGR289c AGT1 2 General alpha-glucoside permease with similarity to maltose permeases and other members of the
sugar permease family
YPR128c ANT1 1 Protein with similarity to ADP/ATP carrier proteins and members of the mitochondrial carrier
family (MCF)
YNL065w AQR1 2 Member of major facilitator superfamily (MFS) multidrug resistance (MFS-MDR) protein family
YER119c AVT6 3 Vacuolar transporter; exports aspartate and glutamate from the vacuole
YDR046c BAP3 3 Branched-chain amino acid permease, valine transporter
YOL137w BSC6 2 MFS protein of unknown function.
YBR290w BSD2 2 Copper ion transporter of the ER; metal homeostasis
YEL063c CAN1 2 Permease for arginine, lysine, and histidine
YJR152w DAL5 2 Allantoate and ureidosuccinate permease, MFS superfamily member
YNL125c ESBP6 2 Protein with similarity to mammalian monocarboxylate transporters MCT1 and MCT2
YAL022c FUN26 3 Nucleoside transporter with broad nucleoside selectivity
YHR094c HXT1 2 Low-affinity hexose transporter and member of sugar permease family; induced by high glucose
YHR096c HXT5 2 Strong similarity to hexose transporters; member of sugar permease family
YFL011w HXT10 2 Hexose transporter; member of sugar permease family
YNR072w HXT17 2 Similarity to hexose transporters, including Hxt13p, Hxt16p, Hxt6p, Hxt7p, and Lgt1p
YNL268w LYP1 2 Lysine-specific permease, high affinity
YDL247w MPH2 2 Alpha-glucoside permease
YGR055w MUP1 2 High-affinity methionine permease
YHL036w MUP3 2 Low-affinity methionine permease
YJL117w PHO86 3 Phosphate permease
YOR348c PUT4 2 Proline and gamma-aminobutyrate permease
YDL199c YDL199c 3 Similarity to members of the sugar permease family
YIL120w YIL120w 2 Member of MFS-MDR protein family
YKL174c YKL174c 2 Similarity to Hnm1p and other permeases
YMR155w YMR155w 2 Unknown function, MFS superfamily member
YPL264c YPL264c 2 Unknown function, MFS superfamily member
YPR003c YPR003c 2 Member of the sulfate permease subfamily of MFS superfamily
Miscellaneous
YCR048w ARE1 2 Acyl coenzyme A (CoA):sterol acyltransferase (sterol-ester synthetase)
YNR019w ARE2 2 Acyl-CoA:sterol acyltransferase (sterol-ester synthetase)
YHR018c ARG4 2 Argininosuccinate lyase; arginine biosynthesis
YPR201w ARR3 2 Arsenic resistance protein
YJL170c ASG7 2 Protein expressed only in cells of mating type a
YBR128c ATG14 2 Required for autophagy
YPR171w BSP1 2 Binding protein of synaptojamin polyphosphoinositide phosphate domain
YLR438w CAR2 2 Ornithine aminotransferase
YIL003w CFD1 3 Putative P-loop ATPase localized in cytoplasm
YLL018c DPS1 2 Aspartyl-tRNA synthetase, cytosolic
YLR284c EHD1 1 Enoyl-CoA hydratase, peroxisomal
YHR123w EPT1 2 sn-1,2-Diacylglycerol ethanolaminephosphotransferase
YFL022c FRS2 1 Phenylalanyl-tRNA synthetase, beta subunit, cytoplasmic
YEL042w GDA1 1 Guanosine diphosphatase of Golgi membrane
YHR183w GND1 3 6-Phosphogluconate dehydrogenase
YPL059w GRX5 1 Mitochondrial glutaredoxin
YJR069c HAM1 1 Protein controlling 6-N-hydroxylaminopurine sensitivity and mutagenesis
YDR224c HTB1 2 Histone H2B
YDL125c HNT1 2 Member of the HIT family of Zn-binding proteins and the histidine triad nucleotide-binding
protein family
Continued on following page
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strengths with the Hsp82(E33A)-BD bait (based on 3-AT-
resistant growth) and their annotated functions in SGD (www
.yeastgenome.org).
Confirmation by protein binding that the E33A mutation
strengthens interactions of Hsp82 with actin and with Slt2p.
The demonstration that a two-hybrid interaction is stabilized
by the E33A mutation in Hsp82-BD can constitute only a first
step towards showing the biological relevance of this interac-
tion in terms of a functional Hsp90 complex (see Discussion).
It was necessary therefore to validate this approach in studies
of direct protein binding. To this end, investigations were con-
ducted into the effects of the E33A and D79N mutations in
Hsp82 binding to two proteins that, in the above screen, inter-
acted more strongly with the Hsp82(E33A)-BD bait as com-
pared to the control Hsp82-BD fusion. One, actin, represented
a protein with well-established Hsp90-binding properties (41),
whereas the other, Slt2p MAP kinase, had not previously been
shown to bind Hsp90.
PJ694 cells were transformed with TRP1 plasmid vectors for
the expression of C terminally His6-tagged wild-type Hsp82
(Hsp82-His6), as well as E33A and D79N mutant versions
of this Hsp82-His6 [Hsp82(E33A)-His6 and Hsp82(D79N)-
His6 respectively; see Materials and Methods]. Protein extracts
were then prepared from vegetative 25°C, unstressed) cultures
of these transformants, the His6-tagged Hsp82 of these extracts
being isolated on a nickel-nitrilotriacetate (Ni-NTA) affinity
resin. Western blot analysis of the Ni-NTA-retained mate-
rial revealed that the E33A mutation was reinforcing the
Hsp82-His6 association with actin (Fig. 2b), whereas D79N
did not generate any such association, thus confirming the
results of the two-hybrid screen (Fig. 2a).
Analysis of Slt2p MAP kinase in the same Ni-NTA-retained
protein samples indicated that Hsp82-His6 association with this
Slt2p was also being reinforced by the E33A mutation but was
abolished totally by D79N (Fig. 2b). Some Slt2p binding to the
nonmutant Hsp82-His6 was also apparent, consistent with a
fairly weak two-hybrid interaction of the nonmutant Hsp82-
TABLE 1—Continued
ORFc Gene Inta Function of gene productb
YPR033c HTS1 1 Histidyl-tRNA synthetase, mitochondrial and cytoplasmic
YOL065c INP54 2 Inositol polyphosphate 5-phosphatase
YOL101c IZH4 2 Membrane protein involved in zinc metabolism
YDL131w LYS21 2 Homocitrate synthase, involved in lysine metabolism
YDL078c MDH3 1 Malate dehydrogenase, peroxisomal
YKL001c MET14 2 Adenosine-5-phosphosulfate 3-phosphotransferase; sulfate assimilation pathway
YIL014w MNT3 2 Alpha-1,3-mannosyltransferase
YNL110c NOP15 2 Constituent of 66S preribosomal particles
YGL055w OLE1 3 Stearoyl-CoA desaturase (delta-9 fatty acid desaturase); synthesis of unsaturated fatty acids
YOL147c PEX11 2 Peroxisomal biogenesis
YBR035c PDX3 2 Pyridoxine (pyridoxamine) phosphate oxidase
YHR037w PUT2 1 Delta-1-pyrroline-5-carboxylate dehydrogenase
YOR347c PYK2 1 Pyruvate kinase, glucose-repressed isoform
YCR106w RDS1 2 Regulator of drug sensitivity
YOL120c RPL18A 2 Ribosomal protein L18A
YPL152w RRD2 1 Protein involved in rapamycin sensitivity
YDL244w THI13 1 Thiamine synthesis
YER100w UBC6 2 Ubiquitin-conjugating enzyme anchored in the ER membrane, with catalytic activity facing into
cytoplasm
YBR273c UBX7 2 Ubiquitin regulatory X domain-containing protein; interacts with Cdc48p
YKL035w UGP1 2 UDP-glucose pyrophosphorylase (UTP-glucose-1-P uridylyltransferase) (UGPase)
YBR130c SHE3 2 Required for mother cell-specific expression of HO
YER118c SHO1 3 Osmosensor in the Hog1p MAP kinase; high-osmolarity signal transduction pathway
YML066c SMA2 1 Spore membrane assembly
YJR159w SOR1 1 Sorbitol dehydrogenase
YMR101c SRT1 1 cis-prenyltransferase involved in dolichol synthesis
YIR011c STS1 1 Protein that when overexpressed restores protein transport and rRNA stability to a sec23 mutation
YPL048w TEF3 1 Translation elongation factor EF-1gamma
YNL131w TOM22 2 Component of mitochondrial outer membrane receptor complex; required for protein import and
cell viability
YOR332w VMA4 2 Vacuolar H-ATPase hydrophilic (27-kDa) subunit
YOR083w WHI5 2 Cell size regulation of passage through start and commitment to cell division
YLR070c XYL2 2 Xylitol dehydrogenase
YJL114w YJL114w 1 TyA Gag protein; main structural constituent of virus-like particles
a Strength of interaction. 1, 2, and 3 indicate growth of the cells containing this interactor and the Hsp82(E33A)-BD bait to 4 mM, 8 mM, or 20 mM 3-AT,
respectively.
b Listed where a function has been assigned. The following are the ORFs encoding interactors of unknown function, with the corresponding gene name, where
assigned, and the interaction strength of the encoded interactor in parentheses: YAL049c (1); YBR220c (2); YBR227c (1); YCL056c (2); YCR101c (3); YDL012c (2);
YDL015c (TSC13) (2); YDL133w (1); YDL180w (1); YDL246c (SOR2) (1); YDL248c (COS7) (2); YDR051c (1); YDR281c (PHM6) (2); YDR319c (2); YDR412w
(1); YER156c (2); YHR036w (2); YGR295c (COS6) (2); YIL041w (3); YIL146c (ECM37) (2); YIR030c (DCG1) (1); YIR042c (2); YJL060w (BNA3) (2); YJR083c
(ACF4) (3); YJR134c (2); YKL008c (LAC1) (2); YKL069w (2); YKR030w (GMH1) (3); YKR044w (UIP5) (2); YKR067w (1); YLR036c (1); YLR404w (2); YML131w
(2); YML132w (COS3) (2); YMR159c (SAP18) (2); YNL100w (1); YNL194c (1); YNL326c (2); YOL026c (MIM1) (1); YOR097c (2); YPL014w (1); YPL109c (1);
YPL156c (PRM2) (1); YPL186c (UIP4) (1); YPL188w (POS5) (1); YPL199c (2); YPL246c (RBD2) (1); YPL257w (2); YPR089w (3); YPR115w (2); YPR127w (2);
YPR148c (1).
c ORF, open reading frame.
d Mating type cassettes on chromosome 3.
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BD and AD-Slt2p fusions (growth to 2 mM 3-AT [Fig. 3c] but
not 4 mM 3-AT [Fig. 2a]).
Caffeine or heat shock generate an increased Hsp82 binding
to Slt2p MAP kinase. Slt2p is one of five MAP kinases of
S. cerevisiae and the terminal MAP kinase of a signaling cas-
cade that becomes activated in response to either a weakening
of the cell wall or the need for polarized growth at the cell sur-
face. Cell wall integrity is monitored continuously by Rho1p, a
GTPase that acts as both a regulatory subunit of the 1,3--
glucan synthase complex and an activator of protein kinase C
(Pkc1p) (see references 13, 21, 24, and 42 for literature). Pkc1p
in turn controls the cell integrity MAP kinase cascade, com-
posed of a MAP kinase kinase kinase (Bck1p) (30), a pair of
redundant MAP kinase kinases (Mkk1/2p) (19), and the Slt2p
stress-activated MAP kinase. There are numerous stress acti-
vators of this pathway, notably hypotonic stress (9), high tem-
perature (23, 34), endoplasmic reticulum stress (5), caffeine
and vanadate (34), and agents that cause cell wall weakening
(12, 26, 53). The pathway is also activated with the polarized
growth of budding and mating (73), as well as with the oper-
ation of the morphogenesis checkpoint (15).
MAP kinases are characteristically activated through dual
threonine/tyrosine phosphorylation of a TXY motif, found
within an activation loop some distance from the active site of
the enzyme (6, 61). Yeast Slt2p exhibits a basal activity in
growing cultures but becomes much more strongly activated by
Mkk1/2p-catalyzed phosphorylation of its TEY motif when-
ever the cell integrity MAP kinase pathway undergoes further
stimulation. Heat shock and caffeine are just two of the induc-
ers of this dually Thr190/Tyr192-phosphorylated, active Slt2p
(23, 34). To determine how these stresses would affect the
Hsp82-Slt2p interaction, extracts were prepared from un-
stressed and stressed cultures of the above Hsp82-His6-, Hsp82
(E33A)-His6-, or Hsp82(D79N)-His6-expressing cells, cultures
either in growth at 25°C (unstressed), heat shocked from 25°C
to 39°C for 1 h, or treated with 8 mM caffeine for 1 h. The
Ni-NTA-retained protein of these extracts was then analyzed
by Western blotting. As shown in Fig. 3a, heat or caffeine stress
increased Slt2p binding by Hsp82-His6 and Hsp82(E33A)-
His6. Stress exposure did not, though, restore any capacity for
Slt2p binding to the non-ATP-binding, Hsp82(D79N)-His6 mu-
tant form of the chaperone (Fig. 3a).
PJ694, the two-hybrid strain used for this study, allows quan-
titative measurements of the effects of in vivo stress on the
strength of any two-hybrid interaction through the monitoring
of its interaction-responsive, GAL7 promoter-regulated lacZ
expression. Such measurements readily lend themselves to au-
tomation (37). By this approach the effects of in vivo heat
shock and caffeine stress on the Hsp82-BD “bait”–AD-Slt2p
“prey” interaction were determined, as were the influences of
the E33A and D79N Hsp82-BD mutations on this Hsp82-BD–
AD-Slt2p interaction (see Materials and Methods). As shown
in Fig. 3b, interaction of the wild-type Hsp82-BD and AD-
Slt2p fusions (functional forms of Hsp90 [37] and Slt2p [58] in
yeast) increased under conditions of heat or caffeine stress.
Interaction was reinforced strongly by the presence of the
E33A mutation in the Hsp82-BD fusion but was abolished
completely by D79N (a result consistent with the protein bind-
ing experiments; Fig. 2b). 3-AT-resistant growth of the same
two-hybrid strains (a monitoring of interaction-responsive
HIS3 gene activation [64]) provided essentially the same result
(Fig. 3c), confirming the importance of the ATP/ADP-inter-
acting D79 residue of the chaperone for any significant inter-
action with Slt2p.
FIG. 3. Effects of heat shock and caffeine stress on interaction of
Hsp82 with the Slt2p MAP kinase. (a) Analysis of the level of Hsp82-
His6-bound Slt2p in extracts from unstressed (25°C), heat shocked
(from 25 to 39°C for 1 h), and caffeine-treated (8 mM for 1 h) cells
expressing either a wild-type, an E33A mutant, or a D79N mutant
Hsp82-His6. The Western blot was probed with anti-Slt2p and anti-
His6 antisera. (b) Quantitation of the strength of Hsp82-BD–AD-Slt2p
interaction (measurements of interaction-responsive lacZ expression
in strain PJ694), showing that the Hsp82-BD–AD-Slt2p interaction in
the two-hybrid system is moderately reinforced by stress, strongly re-
inforced by the E33A mutation, which inhibits the ATPase reaction of
Hsp82, but abolished by the D79N mutation, inhibiting ATP/ADP bind-
ing by the chaperone. The control cells (pBDC) expressed AD-Slt2p but
contained empty pBDC, since basal lacZ expression in this system is
generally due to the AD fusion (37). (c) 3-AT-resistant growth of the
same PJ694 cells expressing the wild-type (WT) or the E33A or D79N
mutant form of Hsp82-BD in conjunction with either a wild-type AD-
Slt2p fusion (WT), a nonphosphorylatable (T190A,Y192F) or phos-
phorylatable, yet kinase-dead (K54R), mutant form of this AD-Slt2p,
or a C terminally truncated AD-Slt2p [AD-Slt2(t)p] (t). Growth was
for 16 days at 30°C on DO minus leucine, tryptophan, and histidine
and supplemented with 2 mM 3-AT.
VOL. 4, 2005 Hsp90 DEPENDENCE OF Slt2p (Mpk1p) MAP KINASE 855
 o
n
 February 24, 2015 by UNIV O
F SUSSEX
http://ec.asm
.org/
D
ow
nloaded from
 
Hsp82 binds exclusively to the dually Thr190/Tyr192-phos-
phorylated, stress-activated form of Slt2p MAP kinase. The
above results indicated that Slt2p was interacting with Hsp82
when the latter was in ATP-bound form, the state of the chap-
erone present in late-stage complexes of the Hsp90 cycle.
Slt2p-Hsp82 association was reinforced by heat or caffeine
(Fig. 3), conditions of in vivo stress that increase the dual
phosphorylation of Slt2p (23, 34). This indicated that Hsp82
might be binding more tightly to, or exclusively to, the dually
Thr/Tyr-phosphorylated form of Slt2p, the state corresponding
to the active MAP kinase.
Vectors were constructed for the in vivo expression of a
functional, C terminally His6-tagged Slt2p (Slt2-His6), as well
as two nonfunctional mutant forms of this Slt2-His6 (see Ma-
terials and Methods). The mutant forms were a T190A Y192F
double mutant (corresponding to conservative substitutions of
the TEY motif residues that must become phosphorylated for
MAP kinase activity) and K54R (a mutation which generates a
phosphorylatable, yet catalytically dead Slt2p [33]). These plas-
mids for Slt2-His6, Slt2(T190A,Y192F)-His6, and Slt2(K54R)-
His6 expression were then transformed into an slt2 yeast strain
that expresses, at a constant level from the TDH1 promoter, just
the Hsp82 isoform of yeast Hsp90 (p82aslt2; see Materials and
Methods). Expression of these Slt2-His6 forms in an slt2 back-
ground eliminated the possibility of heterodimer formation with a
native, chromosomally derived Slt2p (MAP kinases can undergo
dimerization in response to the structural changes induced by
dual Tyr/Thr phosphorylation [28]). Finally, extracts were pre-
pared from these p82aslt2 cells expressing Slt2-His6, Slt2
(T190A,Y192F)-His6, or Slt2(K54R)-His6 as their sole Slt2p,
either in growth at 25°C (unstressed), after a heat shock from
25°C to 39°C for 1 h, or following treatment with 8 mM caffeine
for 1 h. The Ni-NTA-retained protein of these extracts was
then analyzed by Western blotting.
As shown in Fig. 4a, stresses that lead to an increased dual
phosphorylation of Slt2p also cause increased Hsp82 binding
by the wild-type (Slt2-His6) and the kinase-dead [Slt2(K54R)-
His6] versions of this MAP kinase. In contrast, the mutations
rendering this MAP kinase nonphosphorylatable (T190A and
Y192F) completely abolished any interaction with Hsp82. Ad-
ditional evidence that Hsp82 binds only the dually Thr/Tyr-
phosphorylated Slt2p was provided by the two-hybrid system,
both through a monitoring of GAL1 promoter-regulated HIS3
expression (3-AT-resistant growth; Fig. 3c) and by quantitative
measurements of GAL7 promoter-regulated lacZ expression
(Fig. 4b). Using PJ694 cells containing the wild-type Hsp82-
BD bait fusion and either the AD-Slt2p, the AD-Slt2p(T190A,
Y192F), or the AD-Slt2p(K54R) prey fusion, the T190A and
Y192F mutations, which render the AD-Slt2p fusion nonphos-
phorylatable, were found to completely abolish Hsp82-BD–
AD-Slt2p interaction (Fig. 3c and 4b). In contrast, the phos-
phorylatable, yet kinase-dead K54R mutant version of this
AD-Slt2p still displayed a stress-reinforced interaction with the
Hsp82-BD fusion (Figs. 3c and 4b). Interaction-responsive
lacZ expression measurements indicated that this K54R mu-
tant AD-Slt2p was exhibiting a slightly enhanced, stress-in-
duced interaction with Hsp82-BD as compared to the wild-type
AD-Slt2p fusion (Fig. 4b).
Slt2p (55.6 kDa) differs from the other MAP kinases of yeast
in having an extended C-terminal domain of uncertain func-
tion. Its closest relative among mammalian MAP kinases, ERK5/
BMK1, also possesses an extended C terminus, and heterolo-
gous expression of ERK5 can substantially provide Slt2p func-
tion in yeast (A. W. Truman, unpublished). In ERK5 this
C-terminal domain is known to contain a transcriptional acti-
vator region (25, 68) and a nuclear localization signal (67).
Nevertheless, the function of Slt2p in yeast is substantially
preserved with loss of a substantial C-terminal region (58). To
determine whether Hsp82 interaction is also preserved with
the loss of this domain, a C terminally truncated Slt2p (amino
acids 1 to 328, essentially just the MAP kinase module) was
expressed as an AD fusion [AD-Slt2(t)p] in the two-hybrid sys-
tem. The Hsp82-BD bait still interacted with this truncated
Slt2(t)p (Fig. 3c), showing that the MAP kinase domain of Slt2p
is alone sufficient for the two-hybrid interaction with Hsp82.
Analysis of the T22Ihsp82 yeast mutant reveals that Hsp90
chaperone function is essential for Slt2p-mediated stimulation
of the Rlm1p transcriptional activator of cell integrity genes.
To search for genetic evidence of whether the action of Slt2p
MAP kinase is Hsp90 dependent in vivo, a set of eight hsp82
FIG. 4. Interaction between Hsp82 and Slt2p is abolished by mu-
tations that prevent dual Thr190/Tyr192 phosphorylation of Slt2p. (a)
Ni-NTA-retained Hsp82 in unstressed (25°C), heat shocked (from 25
to 39°C for 1 h), and caffeine-treated (8 mM for 1 h) cells of the
p82aslt2 strain. Cultures expressed either the wild-type Slt2-His6, a
nonphosphorylatable (T190A,Y192F mutant) Slt2-His6, or a phos-
phorylatable, yet catalytically dead (K54R mutant), Slt2p-His6 as their
sole form of Slt2p MAP kinase. Since the cells also expressed just the
Hsp82 isoform of yeast Hsp90, the protein detected by the anti-yeast
Hsp90 antibody is entirely this isoform. (b) lacZ expression measure-
ment of the basal and stress-induced two-hybrid interactions of the
Hsp82-BD bait with a wild-type AD-Slt2p fusion and with nonphos-
phorylatable (T190A,Y192F) and phosphorylatable, yet kinase-dead
(K54R), mutant forms of this AD-Slt2p The control cells (pBDC)
expressed wild-type AD-Slt2p but contained the empty pBDC vector.
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mutants were investigated for an altered Slt2p-mediated re-
sponse. These are strains temperature sensitive for growth at
37°C due to point mutations in Hsp82, their sole form of the
Hsp90 chaperone (40). They express this Hsp82 to similar
levels (47) but are compromised, to variable degrees, in the
essential Hsp90 function that this Hsp82 confers (40).
While a low, basal activity of the cell integrity pathway is
beneficial for yeast growth, exceptionally high stress-activated
MAP kinase activity is generally extremely detrimental (14,
66). We found that one of these hsp82 mutants lacked the
detrimental effects of overactive Slt2p-mediated signaling that
normally result with the presence of an overactive form of the
Mkk1p MAP kinase kinase activator of Slt2p. As shown in Fig.
5a, the expression of this hyperactive MKK1P386 allele (65) was
not inhibitory for growth of the T22Ihsp82 mutant, though it
was toxic in the isogenic cells expressing the wild-type Hsp82
(strain p82a). T22Ihsp82 is temperature sensitive due to ex-
pression of the T22I point mutant form of Hsp82 as its sole
Hsp90 (40) (lack of high-temperature growth being one of the
phenotypes displayed by Slt2p MAP kinase cascade mutants
[13, 34]). This absence of toxic effects of MKK1P386 expression
in T22Ihsp82 cells (Fig. 5a) was an indication that the T22I
mutant Hsp82 was generating a defect in cell integrity signaling
epistatic to Pkc1p, Bck1p, and Mkk1/2p in the Slt2p MAP
kinase cascade.
Downstream of Mkk1/2p in this signaling cascade is Slt2p,
one of whose direct phosphorylation targets is the Rlm1p trans
activator of cell wall genes. On this Rlm1p transcription factor,
the sites of docking interaction by the dually Thr/Tyr-phos-
phorylated Slt2p and of activating phosphorylation by this
Slt2p are reasonably well characterized (12, 21, 22). Further-
more Rlm1p activity is readily monitored by using a lacZ re-
porter gene regulated by the Rlm1p-responsive promoter of
the YIL117c gene (22). As shown in Fig. 5c, unstressed cells of
the above-mentioned T22Ihsp82 mutant were found to possess
extremely low basal levels of Rlm1p activity. This mutant also
completely lacked the normal increases in this activity that
result from stress stimulation of cell integrity MAP kinase
signaling (Fig. 5c). Nevertheless, even though the T22Ihsp82
mutant exhibits this pronounced Rlm1p activity defect, its
Slt2p still became dually Tyr/Thr phosphorylated in response
to either caffeine or heat stress activation of cell integrity
signaling (Fig. 5b). Therefore, the compromised Hsp82 func-
tion of the T22Ihsp82 mutant, though not abolishing Mkk1/2p-
mediated Slt2p kinasing in response to Pkc1p-mediated signal-
ing (Fig. 5b), is preventing any relay of this activating signal to
the Rlm1p target of this Slt2p. This effect of the T22Ihsp82
allele is strong genetic evidence for an Hsp90 chaperone re-
quirement in this Rlm1p activation by Slt2p. The physical in-
teraction of Hsp82 and dually Tyr/Thr-phosphorylated Slt2p,
identified and characterized in this study (Fig. 2 to 4), is prob-
ably essential in this Hsp90 facilitation of Slt2p MAP kinase
activity.
The fraction of the total cellular Slt2p existing as the dually
Thr190/Tyr192-phosphorylated form was higher in the heat-
shocked cells of the T22Ihsp82 mutant as compared to that in
the identically stressed control cells expressing the wild-type
Hsp82 (Fig. 5b). This might reflect sensing of a weakened cell
wall in this mutant (one of the signals for Slt2p pathway acti-
vation being sensing of a weakening of cell wall architecture;
see above). Alternatively, it might be due to a compromised
dephosphorylation of the active Slt2p in T22Ihsp82 mutant
cells by the multiple phosphatases that inactivate this MAP
kinase in vivo (7, 11, 14).
FIG. 5. Analysis of the T22Ihsp82 mutant phenotype. (a) The
MKK1S386P allele is toxic in strain p82a, which expresses wild-type Hsp82
as its sole Hsp90, but not in the T22Ihsp82 mutant, which is isogenic
but for expression of the T22I mutant form of this Hsp82. Cells con-
taining either empty vector (pUT36) or a plasmid for MET25 promot-
er-regulated expression of this overactive MKK1 allele were plated on
either methionine-containing or methionine-deficient DO and grown
for 2 days at the indicated temperature. (b) Measurement of dually
phosphorylated Slt2p [(Y-P,T-P)Slt2p] and total Slt2p levels in un-
stressed, heat-shocked, or caffeine-stressed cells of the T22Ihsp82 mu-
tant and its corresponding wild type, p82a. (c) Measurements of Rlm1p
activity in the same unstressed, caffeine-stressed, or heat-shocked p82a
and T22Ihsp82 cells, either growing at 25°C, treated with 8 mM caf-
feine for 1 h at 25°C, or heat shocked from 25°C to 39°C for 1 h.
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DISCUSSION
Protein chaperones often engage in rather transient associ-
ations with their target proteins, preventing an analysis of these
associations by the conventional two-hybrid system. This study
though revealed that many associations of Hsp90 can be sta-
bilized in vivo using a mutation that inhibits the essential
ATPase reaction of the Hsp90 chaperone cycle. The E33A
mutation in the Hsp82-BD two-hybrid bait strongly reinforced
the interactions of this bait with about 3% of the yeast pro-
teome, the latter expressed as AD fusions (Table 1). That
many of the interactors are known cochaperones or clients of
the yeast Hsp90 system (Fig. 1) is a strong indication that this
E33A mutant Hsp82-BD bait is allowing the detection of bona
fide Hsp90 associations. This screening approach is therefore
potentially of use in finding new binding partners of Hsp90,
though it is improbable that it could reveal every Hsp90 inter-
actor in the cell (false negatives arise for a large number of
reasons in two-hybrid screens) (3). Indeed, while our screen
succeeded in identifying some of the known Hsp90 clients of
yeast (10, 29, 31), it also failed to identify others (1, 17, 18).
Table 1 lists the protein fusions selected by the E33A mutant
Hsp82-BD bait. For most of these, further work is needed to
confirm whether or not the two-hybrid association is meaning-
ful in terms of a biologically relevant Hsp90 complex. It is
noteworthy that a few other chaperones and chaperonins of
yeast were identified as putative Hsp90 interactors (Table 1).
They include Hsp60/Hsp10, the functional equivalent of the
bacterial GroEL/ES in mitochondria. Since yeast Hsp90 is
localized to the cytosol (and probably also the nucleus), the
detected interactions (also the interaction with the Grx5p mi-
tochondrial glutaredoxin) might be to the precursor forms of
these proteins that exist prior to mitochondrial import, espe-
cially since the presence of the Gal4p AD at the N termini of
these protein fusions may interfere with the recognition of
signal sequences for mitochondrial import. In mammalian sys-
tems the Hsp70/Hsp90 chaperone system delivers mitochon-
drial protein precursors to the preprotein translocase of the
outer mitochondrial membrane, but it appears that this process
is not Hsp90 dependent in yeast (70). Nevertheless, a com-
ponent of the multisubunit mitochondrial import receptor,
Tom22p, was identified as a potential Hsp90 interactor in this
screen.
A few cytoskeletal proteins (actin, tropomyosin, and Cdc12p)
and chaperones/cochaperones involved in cytoskeletal function
(Cct4p, Hsp42, and She4p) were identified as potential Hsp90
binding partners (Table 1). Hsp90 has long been known to
possess actin-binding properties (41). There is also a constant
requirement for Hsp90 function in the organization of actin
microfilaments, as indicated by an almost immediate delocal-
ization of rhodamine-phalloidin staining and loss of polarized
growth in yeast cells treated with Hsp90 inhibitor drugs (S. H.
Millson, unpublished observations). Certain Rab/Ras small
GTPase protein family members were also apparent Hsp90
interactors (Table 1). This is consistent with the recently dis-
covered role of a Rab-recycling, membrane-associated Hsp90
chaperone complex in operation of the alphaGDP-dissociation
inhibitor. The latter acts in the Rab-mediated targeting of
vesicles to an acceptor compartment, coordinating the Ca2-
dependent events that trigger the hydrolysis of Rab-bound
GTP with the retrieval of the product of this reaction, Rab-
GDP, from vesicle membranes to the cytosol (54). Among the
other potential Hsp90 interactors were 28 known or potential
membrane transporter proteins, including no less than six of
the plasma membrane permeases for amino acids (Table 1).
This is unexpected, since the two-hybrid system requires BD-
and AD-containing fusions to associate noncovalently in the
yeast nucleus. Possibly the fusion of these membrane proteins
to the Gal4p AD, a domain with a nuclear import signal, has
allowed their mislocalization to the nucleus. Only further work
will tell if this apparent Hsp90 association with membrane
transporters is of biological significance.
The E33A mutation inhibits the final, essential ATPase step
of the Hsp90 chaperone cycle and the ensuing release of the
activated client protein (43). Client proteins interacting with
this mutant Hsp90 should therefore accumulate as a late-stage
chaperone complex, stabilized in association with the ATP-
bound chaperone. When expressed at normal cellular Hsp90
levels, the E33A mutant Hsp82 cannot provide the essential
Hsp90 function in yeast (43). This mutant Hsp82 can though
allow very slow growth when highly overexpressed as the sole
Hsp90 of yeast cells (unpublished observations). An E33A
mutant Hsp82 must therefore be capable of very slow progres-
sion through the chaperone cycle. It might be argued that the
two-hybrid interactions detected on the basis of this E33A
mutation are artifacts of such slow cycle progression and the
resultant alterations to the stoichiometry of the different Hsp90
complexes in the yeast. It was necessary therefore to validate this
approach for revealing new Hsp90 binding partners by confirming
that an interaction reinforced by the E33A mutation involves a
hitherto-unidentified Hsp90 client (Fig. 2b to 5).
Just 6 of the 117 yeast protein kinases exhibited a reinforced
two-hybrid interaction dependent on the E33A mutation in the
Hsp82-BD bait (Table 1). Nevertheless, these included two of
the kinases already identified as Hsp90 clients, as well as
three of the five MAP kinases of yeast. We were particularly
intrigued by the latter finding since, while an Hsp90 depen-
dence has been shown for a number of MAP kinase pathway
signaling events (see below), the MAP kinase family kinases
that are the targets of this signaling are not generally regarded
as Hsp90 clients. Indeed, it would seem that Hsp90 is not
required for the activity of many of these kinases (for example,
recombinant ERK2 and p38 can be obtained in active states
by Escherichia coli expression in the absence of eukaryotic
forms of Hsp90 [4, 27]). We therefore sought to establish
whether one of the MAP kinases identified in the screen was
Hsp90 binding and Hsp90 dependent in its activity. As shown
in Fig. 3 and 4, Slt2p interaction is specific for the ATP-bound
form of Hsp82 and the dually Thr190/Tyr192-phosphorylated,
stress-activated state of Slt2p, most probably as a late-stage
Hsp90 chaperone complex. The phenotype of the T22Ihsp82
mutant indicates, in turn, that Hsp90 function is essential for
this dually phosphorylated Slt2p to activate one of its targets,
the Rlm1p trans activator of cell wall genes (Fig. 5). It is
probable therefore that the Slt2p-Hsp82 interaction, identified
and characterized in this study (Fig. 2 to 4), is essential for
Slt2p MAP kinase activity.
This Hsp90 requirement in the action of Slt2p may represent
the Hsp90 machine participating in the formation of the active
Slt2p MAP kinase in response to the structural changes in-
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duced in this MAP kinase as a consequence of the activating
Thr/Tyr phosphorylation. Alternatively, a phosphorylation-in-
duced dimerization of Slt2p (as in mammalian ERK2 [28]) may
be an essential step before Hsp90 (also a dimeric protein) is
able to bind to Slt2p and promote its interaction with the MAP
kinase docking site (D domain) on Rlm1p. A third possibility
is that the Hsp90 function is required for the ability of Slt2p to
phosphorylate its targets after the docking interaction. Future
work should readily distinguish which of these events in the
operation of this client protein require the Hsp90 chaperone.
A number of the signaling events of MAP kinase pathway
activation are known to be Hsp90 dependent. In Schizosaccha-
romyces pombe the Hsp90 cochaperone Cdc37p is involved in
Spc1p stress-activated MAP kinase signaling and cdc37 muta-
tions affect both Spc1p level and Spc1p phosphorylation by the
Wis1p stress-activated MAP kinase kinase (62). Hsp90 is also
needed for the activity of Ste11p, a MAP kinase kinase kinase
of S. cerevisiae that signals to no less than two MAP kinases,
Kss1p and Hog1p (31). In addition, Hsp90 binding stabilizes
mammalian Mok1p, a protein kinase that is structurally mod-
erately related to conventional MAP kinases and activated
during spermatogenesis (39). Nevertheless stress-activated
MAP kinases, such as the Hog1p and Slt2p of S. cerevisiae, the
Sty1p of S. pombe, and the p38 of mammalian systems, have
not previously been considered as Hsp90-dependent activities.
As a MAP kinase with well-established genetics (5, 9, 12, 15,
23, 26, 34, 53, 73), Slt2p should be an ideal model protein with
which to investigate the Hsp90 dependence of protein kinase
activity.
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ADDENDUM IN PROOF
While this paper was in press, the results of another two-
hybrid screen for Hsp90 interactors were published (R. Zhao,
M. Davey, Y. C. Hsu, P. Kaplanek, A. Tong, A. B. Parsons, N.
Krogan, G. Cagney, D. Mai, J. Greenblatt, C. Boone, A. Emili,
and W. A. Houry, Cell 120:715–727, 2005). While both studies
have identified some common interactors (e.g., Tah1p, Slt2p),
there are also major differences between our findings and the
findings of this latest study. These can be largely attributed to
the use of different bait fusions in the screens. Zhao et al. used
a bait comprising the Ga14p BD positioned at the N terminus
of the wild-type Hsp82 sequence, a BD-Hsp82 fusion that
cannot provide the essential Hsp90 chaperone function in vivo
(38). Our screen, in contrast, relied upon the introduction of
an interaction-stabilizing mutation (E33A) in a fusion (Hsp82-
BD) where the BD is placed at the Hsp82 C terminus. The
latter fusion is substantially functional as an Hsp90 chaperone
in vivo (37, 38).
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